Study on the Dose-Effect Relationship of Ginger-Partitioned Moxibustion in the Treatment of Allergic Rhinitis

Shanghai TCM-Integrated Hospital0 个研究点开始时间: 待定最近更新: 2023年2月20日

适应症

试验速览

暂无简介。

•1. Men or women aged 18 to 60 years;
•2. Those who have perennial allergic rhinitis;
•3. Those who meet diagnostic criteria of allergic rhinitis;
•4. Those who have not used any drugs or treatment methods for allergic rhinitis 2 weeks before the trial;
•5. Those who accept ginger moxibustion treatment;
•6. Those who are willing to cooperate with this trial treatment plan;
•7. Those who are willing to sign an informed consent form.

•1. Those who are allergic to smoke and dust produced by moxibustion;
•2. Those who are pregnant, breastfeeding during the study period;
•3. Those who have serious disease related to the blood vessel, liver, kidney or haematopoietic system;
•4. Those who have mental illness;
•5. Those who are complicated with rhinosinusitis, otitis media, nasal polyps, nasal septum deviation and other ENT infections or organic lesions;
•6. Those who have asthma and other paroxysmal respiratory diseases and are in the attack period;
•7. Those who are participating in the other clinical trials of moxibustion.

发起方

Shanghai TCM-Integrated Hospital